发明名称 Redirection of cellular immune response by administering protein-tyrosine kinase chimeras
摘要 Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal a chimeric receptor which causes the cells to specifically recognize and destroy an infective agent, a cell infected with an infective agent, a tumor or cancerous cell, or an autoimmune-generated cell. The chimeric receptor includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent, and (b) an intracellular portion of a protein-tyrosine kinase which is capable of signalling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent. Also disclosed are cells which express the chimeric receptors and DNA encoding the chimeric receptors.
申请公布号 NZ501340(A) 申请公布日期 2004.12.24
申请号 NZ19960501340 申请日期 1996.01.24
申请人 GEN HOSPITAL CORP 发明人 SEED BRIAN;ROMEO CHARLES;KOLANUS WALDERMAR
分类号 C12N15/09;A61K35/12;A61K35/14;A61K38/00;A61K48/00;C07K14/705;C07K14/725;C07K14/73;C07K14/735;C07K19/00;C12N5/08;C12N5/10;C12N9/12;C12N15/62;C12N15/863;(IPC1-7):A61K48/00;C12N15/79;C12N5/00;C12N15/63;C12N15/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址